{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:11:16Z","timestamp":1790061076622,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:00:00Z","timestamp":1212019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00210-008-0310-y","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T10:08:46Z","timestamp":1211969326000},"page":"283-291","source":"Crossref","is-referenced-by-count":39,"title":["Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients"],"prefix":"10.1007","volume":"378","author":[{"given":"Nicole","family":"Schupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Dette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Heidland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Stopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,29]]},"reference":[{"key":"310_CR1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1681\/ASN.2004080635","volume":"16","author":"S Agalou","year":"2005","unstructured":"Agalou S, Ahmed N, Babaei-Jadidi R et al (2005) Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 16:1471\u20131485","journal-title":"J Am Soc Nephrol"},{"key":"310_CR2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","volume":"52","author":"R Babaei-Jadidi","year":"2003","unstructured":"Babaei-Jadidi R, Karachalias N, Ahmed N et al (2003) Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52:2110\u20132120","journal-title":"Diabetes"},{"issue":"Suppl 7","key":"310_CR3","first-page":"vii46","volume":"18","author":"C Basile","year":"2003","unstructured":"Basile C (2003) The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 18(Suppl 7):vii46\u201349 discussion vii58\u201349","journal-title":"Nephrol Dial Transplant"},{"key":"310_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem 239:70\u201376","journal-title":"Anal Biochem"},{"key":"310_CR5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","volume":"37","author":"A Bierhaus","year":"1998","unstructured":"Bierhaus A, Hofmann MA, Ziegler R et al (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37:586\u2013600","journal-title":"Cardiovasc Res"},{"key":"310_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/carcin\/bgl177","volume":"28","author":"S Bonassi","year":"2007","unstructured":"Bonassi S, Znaor A, Ceppi M et al (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625\u2013631","journal-title":"Carcinogenesis"},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1525-1594.2004.47315.x","volume":"28","author":"T Boure","year":"2004","unstructured":"Boure T, Vanholder R (2004) Biochemical and clinical evidence for uremic toxicity. Artif Organs 28:248\u2013253","journal-title":"Artif Organs"},{"key":"310_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000097080","volume":"24","author":"M Buemi","year":"2006","unstructured":"Buemi M, Floccari F, Costa C et al (2006) Dialysis-related genotoxicity: sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients. Genomic damage in patients on hemodiafiltration. Blood Purif 24:569\u2013574","journal-title":"Blood Purif"},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-4608(88)90075-1","volume":"36","author":"K Cengiz","year":"1988","unstructured":"Cengiz K, Block AM, Hossfeld DK et al (1988) Sister chromatid exchange and chromosome abnormalities in uremic patients. Cancer Genet Cytogenet 36:55\u201367","journal-title":"Cancer Genet Cytogenet"},{"key":"310_CR10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s001250100529","volume":"44","author":"A Ceriello","year":"2001","unstructured":"Ceriello A, Mercuri F, Quagliaro L et al (2001) Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44:834\u2013838","journal-title":"Diabetologia"},{"key":"310_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/japplphysiol.00988.2005","volume":"100","author":"AF Ceylan-Isik","year":"2006","unstructured":"Ceylan-Isik AF, Wu S, Li Q et al (2006) High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol 100:150\u2013156","journal-title":"J Appl Physiol"},{"key":"310_CR12","doi-asserted-by":"crossref","first-page":"25409","DOI":"10.1074\/jbc.272.41.25409","volume":"272","author":"DL Croteau","year":"1997","unstructured":"Croteau DL, Bohr VA (1997) Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272:25409\u201325412","journal-title":"J Biol Chem"},{"key":"310_CR13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0278-6915(02)00028-5","volume":"40","author":"M Fenech","year":"2002","unstructured":"Fenech M (2002) Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol 40:1113\u20131117","journal-title":"Food Chem Toxicol"},{"key":"310_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1383-5742(99)00053-8","volume":"428","author":"M Fenech","year":"1999","unstructured":"Fenech M, Holland N, Chang WP et al (1999) The HUman MicroNucleus Project\u2014an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 428:271\u2013283","journal-title":"Mutat Res"},{"key":"310_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","volume":"534","author":"M Fenech","year":"2003","unstructured":"Fenech M, Chang WP, Kirsch-Volders M et al (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65\u201375","journal-title":"Mutat Res"},{"key":"310_CR16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/carcin\/bgi042","volume":"26","author":"M Fenech","year":"2005","unstructured":"Fenech M, Baghurst P, Luderer W et al (2005) Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability\u2013results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26:991\u2013999","journal-title":"Carcinogenesis"},{"key":"310_CR17","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/ndt\/gfh898","volume":"20","author":"E Fragedaki","year":"2005","unstructured":"Fragedaki E, Nebel M, Schupp N et al (2005) Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant 20:1936\u20131943","journal-title":"Nephrol Dial Transplant"},{"key":"310_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002280000131","volume":"56","author":"T Frank","year":"2000","unstructured":"Frank T, Bitsch R, Maiwald J et al (2000) High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine. Eur J Clin Pharmacol 56:251\u2013257","journal-title":"Eur J Clin Pharmacol"},{"key":"310_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00125-005-0103-5","volume":"49","author":"S Gadau","year":"2006","unstructured":"Gadau S, Emanueli C, Van Linthout S et al (2006) Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B\/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia 49:405\u2013420","journal-title":"Diabetologia"},{"key":"310_CR20","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1523-1755.2004.00961.x","volume":"66","author":"G Glorieux","year":"2004","unstructured":"Glorieux G, Helling R, Henle T et al (2004) In vitro evidence for immune activating effect of specific AGE structures retained in uremia. Kidney Int 66:1873\u20131880","journal-title":"Kidney Int"},{"key":"310_CR21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes HP, Du X, Edelstein D et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9:294\u2013299","journal-title":"Nat Med"},{"key":"310_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5414\/CPP43071","volume":"43","author":"E Haupt","year":"2005","unstructured":"Haupt E, Ledermann H, Kopcke W (2005) Benfotiamine in the treatment of diabetic polyneuropathy\u2013a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43:71\u201377","journal-title":"Int J Clin Pharmacol Ther"},{"key":"310_CR23","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","volume":"62","author":"J Himmelfarb","year":"2002","unstructured":"Himmelfarb J, Stenvinkel P, Ikizler TA et al (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524\u20131538","journal-title":"Kidney Int"},{"key":"310_CR24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/ajkd.2001.28578","volume":"38","author":"SC Hung","year":"2001","unstructured":"Hung SC, Hung SH, Tarng DC et al (2001a) Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 38:941\u2013947","journal-title":"Am J Kidney Dis"},{"key":"310_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/ajkd.2001.21337","volume":"37","author":"SC Hung","year":"2001","unstructured":"Hung SC, Hung SH, Tarng DC et al (2001b) Chorea induced by thiamine deficiency in hemodialysis patients. Am J Kidney Dis 37:427\u2013430","journal-title":"Am J Kidney Dis"},{"key":"310_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1383-5718(02)00205-X","volume":"520","author":"E Kan","year":"2002","unstructured":"Kan E, Undeger U, Bali M et al (2002) Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation. Mutat Res 520:151\u2013159","journal-title":"Mutat Res"},{"key":"310_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02254982","volume":"9","author":"PS Lim","year":"2002","unstructured":"Lim PS, Ma YS, Cheng YM et al (2002) Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. J Biomed Sci 9:549\u2013560","journal-title":"J Biomed Sci"},{"key":"310_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/16.3.561","volume":"16","author":"CS Liu","year":"2001","unstructured":"Liu CS, Ko LY, Lim PS et al (2001) Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles. Nephrol Dial Transplant 16:561\u2013565","journal-title":"Nephrol Dial Transplant"},{"key":"310_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","volume":"354","author":"P Maisonneuve","year":"1999","unstructured":"Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93\u201399","journal-title":"Lancet"},{"key":"310_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1523-1755.61.s80.20.x","volume":"80","author":"M Morena","year":"2002","unstructured":"Morena M, Cristol JP, Senecal L et al (2002) Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? Kidney Int Suppl 80:109\u2013114","journal-title":"Kidney Int Suppl"},{"key":"310_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1492-7535.2005.01116.x","volume":"9","author":"M Morena","year":"2005","unstructured":"Morena M, Delbosc S, Dupuy AM et al (2005) Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 9:37\u201346","journal-title":"Hemodial Int"},{"key":"310_CR32","first-page":"669","volume":"35","author":"G Munch","year":"1997","unstructured":"Munch G, Keis R, Wessels A et al (1997) Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35:669\u2013677","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"310_CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.jrn.2006.01.002","volume":"16","author":"MM Nascimento","year":"2006","unstructured":"Nascimento MM, Suliman ME, Murayama Y et al (2006) Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study. J Ren Nutr 16:119\u2013124","journal-title":"J Ren Nutr"},{"key":"310_CR34","first-page":"277","volume":"23","author":"I Pietrzak","year":"1997","unstructured":"Pietrzak I, Baczyk K (1997) Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy. Miner Electrolyte Metab 23:277\u2013282","journal-title":"Miner Electrolyte Metab"},{"key":"310_CR35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s005920170010","volume":"38","author":"F Pomero","year":"2001","unstructured":"Pomero F, Molinar Min A, La Selva M et al (2001) Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose. Acta Diabetol 38:135\u2013138","journal-title":"Acta Diabetol"},{"key":"310_CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(00)70189-2","volume":"35","author":"DS Raj","year":"2000","unstructured":"Raj DS, Choudhury D, Welbourne TC et al (2000) Advanced glycation end products: a Nephrologist\u2019s perspective. Am J Kidney Dis 35:365\u2013380","journal-title":"Am J Kidney Dis"},{"key":"310_CR37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000045934","volume":"87","author":"R Schinzel","year":"2001","unstructured":"Schinzel R, Munch G, Heidland A et al (2001) Advanced glycation end products in end-stage renal disease and their removal. Nephron 87:295\u2013303","journal-title":"Nephron"},{"key":"310_CR38","first-page":"1","volume":"131","author":"ED Schleicher","year":"2001","unstructured":"Schleicher ED, Bierhaus A, Haring HU et al (2001) Chemistry and pathobiology of advanced glycation end products. Contrib Nephrol 131:1\u20139","journal-title":"Contrib Nephrol"},{"key":"310_CR39","doi-asserted-by":"crossref","unstructured":"Schmid U, Stopper H, Heidland A et al (2008) Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro. Diabetes Metab Res Rev (in press)","DOI":"10.1002\/dmrr.860"},{"key":"310_CR40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1521-3803(20010601)45:3<172::AID-FOOD172>3.0.CO;2-U","volume":"45","author":"V Schwenger","year":"2001","unstructured":"Schwenger V, Zeier M, Henle T et al (2001) Advanced glycation endproducts (AGEs) as uremic toxins. Nahrung 45:172\u2013176","journal-title":"Nahrung"},{"key":"310_CR41","first-page":"S9","volume":"53","author":"WG Siems","year":"2000","unstructured":"Siems WG, Sommerburg O, Grune T (2000) Erythrocyte free radical and energy metabolism. Clin Nephrol 53:S9\u201317","journal-title":"Clin Nephrol"},{"key":"310_CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2133.2005.06949.x","volume":"154","author":"GN Stamatas","year":"2006","unstructured":"Stamatas GN, Estanislao RB, Suero M et al (2006) Facial skin fluorescence as a marker of the skin\u2019s response to chronic environmental insults and its dependence on age. Br J Dermatol 154:125\u2013132","journal-title":"Br J Dermatol"},{"key":"310_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","volume":"14","author":"JH Stewart","year":"2003","unstructured":"Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"310_CR44","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","volume":"29","author":"A Stirban","year":"2006","unstructured":"Stirban A, Negrean M, Stratmann B et al (2006) Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29:2064\u20132071","journal-title":"Diabetes Care"},{"key":"310_CR45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0887-2333(97)00084-2","volume":"11","author":"H Stopper","year":"1997","unstructured":"Stopper H, M\u00fcller SO (1997) Micronuclei. Biological end point for genotoxicity. Vitro 11:661\u2013667","journal-title":"Vitro"},{"key":"310_CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0272-6386(99)70069-7","volume":"34","author":"H Stopper","year":"1999","unstructured":"Stopper H, Meysen T, Bockenforde A et al (1999) Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis 34:433\u2013437","journal-title":"Am J Kidney Dis"},{"key":"310_CR47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/ajkd.2001.26094","volume":"38","author":"H Stopper","year":"2001","unstructured":"Stopper H, Boullay F, Heidland A et al (2001) Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis 38:296\u2013301","journal-title":"Am J Kidney Dis"},{"key":"310_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3835(02)00626-2","volume":"190","author":"H Stopper","year":"2003","unstructured":"Stopper H, Schinzel R, Sebekova K et al (2003) Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett 190:151\u2013156","journal-title":"Cancer Lett"},{"key":"310_CR49","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/ajkd.2000.19086","volume":"36","author":"DC Tarng","year":"2000","unstructured":"Tarng DC, Huang TP, Wei YH et al (2000) 8-hydroxy-2\u2032-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36:934\u2013944","journal-title":"Am J Kidney Dis"},{"key":"310_CR50","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1055\/s-2002-35637","volume":"127","author":"M Teschner","year":"2002","unstructured":"Teschner M, Garte C, Ruckle-Lanz H et al (2002) Incidence and spectrum of malignant disease among dialysis patients in North Bavaria. Dtsch Med Wochenschr 127:2497\u20132502","journal-title":"Dtsch Med Wochenschr"},{"key":"310_CR51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.jrn.2006.10.011","volume":"17","author":"S Thijssen","year":"2007","unstructured":"Thijssen S, Wystrychowski G, Usvyat L et al (2007) Determinants of serum albumin concentration analyzed in a large cohort of patients on maintenance hemodialysis. J Ren Nutr 17:70\u201374","journal-title":"J Ren Nutr"},{"key":"310_CR52","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","volume":"50","author":"PJ Thornalley","year":"2007","unstructured":"Thornalley PJ, Babaei-Jadidi R, Al Ali H et al (2007) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50:2164\u20132170","journal-title":"Diabetologia"},{"key":"310_CR53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000013314","volume":"18","author":"S Vamvakas","year":"1998","unstructured":"Vamvakas S, Bahner U, Heidland A (1998) Cancer in end-stage renal disease: potential factors involved -editorial. Am J Nephrol 18:89\u201395","journal-title":"Am J Nephrol"},{"key":"310_CR54","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G et al (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934\u20131943","journal-title":"Kidney Int"},{"key":"310_CR55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/10715760500117472","volume":"39","author":"K Volkovova","year":"2005","unstructured":"Volkovova K, Barancokova M, Kazimirova A et al (2005) Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage. Free Radic Res 39:659\u2013666","journal-title":"Free Radic Res"},{"key":"310_CR56","first-page":"220","volume":"49","author":"G Winkler","year":"1999","unstructured":"Winkler G, Pal B, Nagybeganyi E et al (1999) Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneim-Forsch 49:220\u2013224","journal-title":"Arzneim-Forsch"},{"key":"310_CR57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","volume":"394","author":"S Wu","year":"2006","unstructured":"Wu S, Ren J (2006) Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett 394:158\u2013162","journal-title":"Neurosci Lett"},{"key":"310_CR58","first-page":"129","volume":"23","author":"S Yamagishi","year":"2003","unstructured":"Yamagishi S, Takeuchi M, Inagaki Y et al (2003) Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int J Clin Pharmacol Res 23:129\u2013134","journal-title":"Int J Clin Pharmacol Res"},{"key":"310_CR59","first-page":"303","volume":"17","author":"D Zevin","year":"1991","unstructured":"Zevin D, Malachi T, Gafter U et al (1991) Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab 17:303\u2013306","journal-title":"Miner Electrolyte Metab"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-008-0310-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0310-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:02:16Z","timestamp":1558641736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,29]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0310-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,29]]}}}